Antirobe Capsules 150 mg are indicated for use in dogs as follows: for the treatment of infected wounds and abscesses, and infected mouth cavity and dental infections, caused by or associated with Staphylococcus spp., Streptococcus spp. (except Streptococcus faecalis), Bacteroides spp., Fusobacterium necrophorum, and Clostridium perfringens. To help provide antimicrobial cover during dental procedures.
For the treatment of superficial pyoderma associated with Staphylococcus intermedius.
For the treatment of osteomyelitis, caused by Staphylococcus aureus.
A vet prescription is required for the medicine you have chosen.
If you do not yet have a prescription then you can print out the following blank veterinary Prescription Form which you can ask your vet to fill in when you next visit. Please note that changes to legislation in 2005 means that Vets must offer you a prescription to take away and not just supply you the medicines directly. This is to ensure more competition and lower prices for you.
For oral administration only. For the treatment of infected wounds and abscesses, and infected mouth cavity and dental infections in dogs and cats, administer either: 5.5 mg/kg of bodyweight every 12 hours for 7-10 days, or 11 mg/kg of bodyweight every 24 hours for 7-10 days. If no clinical response is seen within 4 days, redetermine the diagnosis. To help provide antimicrobial cover during dental procedures, a 10 day course is recommended. This should be initiated five days before dental therapy and continued for five days thereafter. In dogs, treatment may be extended to a maximum of 28 days based on clinical judgement. For the treatment of superficial pyoderma in dogs, administer either: 5.5 mg/kg of bodyweight every 12 hours, or 11 mg/kg of bodyweight every 24 hours. For the treatment of osteomyelitis in dogs, administer: 11 mg/kg of bodyweight every 12 hours for a minimum of 28 days. If no clinical response is seen within 14 days, the treatment should be stopped and the diagnosis redetermined.
Clindamycin (as Clindamycin Hydrochloride) 150 mg per capsule, Maize Starch, Talc, Magnesium Stearate,Lactose Monohydrate.
Do not administer to rabbits, hamsters, guinea pigs, chinchillas, horses or ruminants because ingestion of Clindamycin by these species may result in severe gastro-intestinal disturbance. Vomiting and diarrhoea have occasionally been observed. Antirobe sometimes causes the overgrowth of non-sensitive organisms such as resistant clostridia and yeasts. In cases of superinfection, appropriate measures must be taken according to the clinical situation. While high dose studies in rats suggest that clindamycin is not a teratogen and does not significantly affect the breeding performance of males and females, safety in gestating bitches/queens or breeding male dogs/cats has not been established. Clindamycin hydrochloride has been shown to have neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents. Antirobe Capsules should be used with caution in animals receiving such agents. Clindamycin should not be used concomitantly with chloramphenicol or macrolides as they antagonise each other at their site of action at the 50S ribosomal sub-unit.